Rybczynska Jolanta, Campbell Katherine, Kamili Saleem, Locarnini Stephen, Krawczynski Krzysztof, Walker Christopher M
Department of Pathology, Medical University of Warsaw, Poland Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia.
Center for Vaccines and Immunity, Nationwide Children's Hospital.
J Infect Dis. 2016 Jan 1;213(1):49-56. doi: 10.1093/infdis/jiv348. Epub 2015 Aug 31.
Humans vaccinated with hepatitis B virus (HBV) surface antigen (HBsAg) sometimes develop humoral and cellular immunity to HBV proteins such as core and polymerase that are not vaccine components, providing indirect evidence that vaccine-induced immunity is not sterilizing. We previously described CD4(+) T-cell immunity against HBsAg and polymerase in chimpanzees after vaccination and HBV challenge. Here, vaccinated chimpanzees with protective levels of anti-HBsAg antibodies were rechallenged with HBV after antibody-mediated CD4(+) T-cell depletion. HBV DNA was detected in liver for at least 3 months after rechallenge, but virus replication was suppressed, as revealed by the absence of HBV DNA and HBsAg in serum. These observations provide direct virological evidence for nonsterilizing immunity in individuals with anti-HBsAg antibodies and are consistent with translation of HBV proteins to prime immune responses. They also indicate that CD4(+) T cells were not required for suppression of HBV replication in previously vaccinated individuals.
接种乙型肝炎病毒(HBV)表面抗原(HBsAg)的人类有时会对诸如核心蛋白和聚合酶等并非疫苗成分的HBV蛋白产生体液免疫和细胞免疫,这间接证明了疫苗诱导的免疫并非无菌免疫。我们之前描述了黑猩猩在接种疫苗并受到HBV攻击后针对HBsAg和聚合酶的CD4(+) T细胞免疫。在此,在抗体介导的CD4(+) T细胞耗竭后,对具有保护性水平抗HBsAg抗体的接种疫苗的黑猩猩再次进行HBV攻击。再次攻击后至少3个月在肝脏中检测到HBV DNA,但病毒复制受到抑制,血清中未检测到HBV DNA和HBsAg表明了这一点。这些观察结果为具有抗HBsAg抗体的个体中的非无菌免疫提供了直接的病毒学证据,并且与HBV蛋白引发免疫反应的转化一致。它们还表明,在先前接种疫苗的个体中,抑制HBV复制不需要CD4(+) T细胞。